US 12016929
Lipid formulations for delivery of therapeutic agents
granted A61KA61K31/713A61K47/44
Quick answer
US patent 12016929 (Lipid formulations for delivery of therapeutic agents) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/713, A61K47/44, A61K47/543, A61K9/0019